Cost-effectiveness analysis of defibrotide in the treatment of patients with severe veno-occlusive disease/sinusoidal obstructive syndrome with multiorgan dysfunction following hematopoietic cell transplantation in Spain

David Carcedo Rodrigueza Hygeia Consulting, S.L, Madrid, SpainCorrespondence[email protected]

Teresa Artola Urainb Hematology and Hemotherapy Department, Hospital Donostia, País Vasco, Spain

Anabelle Chinea Rodriguezc Hematology and Hemotherapy Services, Hospital Ramón y Cajal, Madrid, Spain

Estefanía García Torresd Hematology Department, Hospital Reina Sofía, Córdoba, Spain

Marta González Vicente Hematology and Hemotherapy Services, Hospital Niño Jesús, Madrid, Spain

Gonzalo Gutiérrez Garcíaf Bone Marrow Transplant Unit – Hospital Clinic of Barcelona, University of Barcelona, IDIBAPS, Barcelona, Spain

Alexandra Regueiro Garcíag Pediatrics Department, C.H.U. de Santiago, Galicia, Spain

Marcos Calvo Hidalgoh Onco-Hematology, Jazz Pharmaceuticals, Iberia, Spain

Alba Villacampaa Hygeia Consulting, S.L, Madrid, Spain

Articles from other publishers (1)